The MPD Foundation promotes meaningful medical research into myeloproliferative disorders - Polycythemia Vera (PV), Essential Thrombocythemia (ET) and Primary Myelofibrosis (PMF)

The MPD Foundation issues a Request for Proposals for its New Investigator Award Program.  Click here for more info The MPD Foundation issues a Request for Proposals for Year 4 of the MPD Research alliance.  Click here for more info Incyte's JAK2 Inhibitor Demonstrates Clinical Benefit for Myelofibrosis Patients in Ongoing Clinical Trial Click here for more Myeloproliferative Disorders News

The MPD Foundation's primary mission is to stimulate and finance original research in pursuit of new treatments and eventually a cure for the myeloproliferative disorders (MPD) which include polycythemia vera, essential thrombocythemia and primary myelofibrosis. As a secondary goal, the MPD Foundation hopes to use the research and therapies developed from the MPD work to benefit a broader range of blood cancers such as multiple myeloma, myelogenic leukemia and lymphocytic leukemia. Lastly, the foundation hopes to give patients and their families the information they need to manage myeloproliferative disorders and minimize the debilitating side effects until an initial cure is found.

100% of All New Donations Go Directly To MPD Research

Search Site:

Related Links:

FOET (Friends of Essential Thrombocythemia)

CMPD Foundation
National Cancer Institute
MPD Research Consortium

© 2004-2008, The Myeloproliferative Disorders Foundation. All rights reserved. Website by JabberDesign.